<!doctype html>
<html lang="en">
<head>
<meta charset="utf-8">
<title>Table3</title>
<style>
  body { font-family: "Courier New", Courier, monospace; margin:0; padding:10px; }
  pre { margin:0; line-height:1; font-size:14px; white-space:pre; }
</style>
</head>
<body>
<pre>Table 3
Shifts in Liver Biochemical Tests Based on Thresholds
&lt;Analysis Set&gt;
                                                                             Maximum Post−Baseline Result
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Maximum Baseline Value                 &lt; 3x ULN     &gt;= 3 to &lt; 5x ULN   &gt;= 5 to &lt; 10x ULN   &gt;= 10 to &lt; 20x ULN    &gt;= 20x ULN       Missing   
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
ALT                                                                                                                                         
  PL (N=355)                                                                                                                                
              &lt; 3x ULN                    0                0                   0               10 (0.7%)          6 (1.4%)           0      
              &gt;= 3 to &lt; 5x ULN            0                0               2 (0.2%)             7 (0.5%)              0              0      
              &gt;= 5 to &lt; 10x ULN        1 (0.1%)            0               3 (0.3%)            40 (2.6%)          19 (4.3%)          0      
              &gt;= 10 to &lt; 20x ULN          0                0               11 (1.2%)           116 (7.6%)        70 (15.9%)          0      
              &gt;= 20x ULN                  0             1 (0.2%)           4 (0.5%)            40 (2.6%)          25 (5.7%)          0      
              Missing                     0                0                   0                   0                  0              0      
  T1 (N=318)                                                                                                                                
              &lt; 3x ULN                    0             1 (0.2%)           1 (0.1%)             5 (0.3%)          7 (1.6%)           0      
              &gt;= 3 to &lt; 5x ULN            0                0                   0                5 (0.3%)          3 (0.7%)           0      
              &gt;= 5 to &lt; 10x ULN           0                0               3 (0.3%)            32 (2.1%)          18 (4.1%)          0      
              &gt;= 10 to &lt; 20x ULN          0                0               6 (0.7%)            98 (6.4%)         79 (18.0%)          0      
              &gt;= 20x ULN                  0             1 (0.2%)           3 (0.3%)            36 (2.4%)          20 (4.5%)          0      
              Missing                     0                0                   0                   0                  0              0      
  T2 (N=326)                                                                                                                                
              &lt; 3x ULN                    0                0                   0                9 (0.6%)          2 (0.5%)           0      
              &gt;= 3 to &lt; 5x ULN            0                0                   0               10 (0.7%)          1 (0.2%)           0      
              &gt;= 5 to &lt; 10x ULN           0                0               3 (0.3%)            30 (2.0%)          17 (3.9%)          0      
              &gt;= 10 to &lt; 20x ULN          0             1 (0.2%)           10 (1.1%)           118 (7.7%)        61 (13.9%)          0      
              &gt;= 20x ULN                  0                0               2 (0.2%)            36 (2.4%)          26 (5.9%)          0      
              Missing                     0                0                   0                   0                  0              0      
AST                                                                                                                                         
  PL (N=355)                                                                                                                                
              &lt; 3x ULN                    0                0               3 (0.3%)             6 (0.4%)              0              0      
              &gt;= 3 to &lt; 5x ULN            0                0                   0                8 (0.5%)              0              0      
              &gt;= 5 to &lt; 10x ULN           0                0               9 (1.0%)            65 (4.3%)          10 (2.3%)          0      
              &gt;= 10 to &lt; 20x ULN          0                0               25 (2.8%)          193 (12.7%)         19 (4.3%)          0      
              &gt;= 20x ULN                  0                0               2 (0.2%)            13 (0.9%)          2 (0.5%)           0      
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
PL=Placebo, T1=Treatment 1, T2=Treatment 2, ALT=alanine aminotransferase, AST=aspartate aminotransferase, ALP=alkaline phosphatase;
N=number of applicable subjects in treatment arm; n=actual applicable observed number with values.
Table 3
Shifts in Liver Biochemical Tests Based on Thresholds
&lt;Analysis Set&gt;
                                                                             Maximum Post−Baseline Result
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Maximum Baseline Value                 &lt; 3x ULN     &gt;= 3 to &lt; 5x ULN   &gt;= 5 to &lt; 10x ULN   &gt;= 10 to &lt; 20x ULN    &gt;= 20x ULN       Missing   
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
AST                                                                                                                                         
  PL (N=355)                                                                                                                                
              Missing                     0                0                   0                   0                  0              0      
  T1 (N=318)                                                                                                                                
              &lt; 3x ULN                    0                0                   0                5 (0.3%)          1 (0.2%)           0      
              &gt;= 3 to &lt; 5x ULN            0                0               2 (0.2%)             9 (0.6%)              0              0      
              &gt;= 5 to &lt; 10x ULN           0                0               9 (1.0%)            60 (3.9%)          2 (0.5%)           0      
              &gt;= 10 to &lt; 20x ULN          0                0               15 (1.7%)          184 (12.1%)         19 (4.3%)          0      
              &gt;= 20x ULN                  0                0               1 (0.1%)             8 (0.5%)          3 (0.7%)           0      
              Missing                     0                0                   0                   0                  0              0      
  T2 (N=326)                                                                                                                                
              &lt; 3x ULN                    0                0                   0                7 (0.5%)          2 (0.5%)           0      
              &gt;= 3 to &lt; 5x ULN            0                0                   0               10 (0.7%)              0              0      
              &gt;= 5 to &lt; 10x ULN           0                0               10 (1.1%)           62 (4.1%)          9 (2.0%)           0      
              &gt;= 10 to &lt; 20x ULN          0             1 (0.2%)           21 (2.4%)          172 (11.3%)         15 (3.4%)          0      
              &gt;= 20x ULN                  0                0                   0               13 (0.9%)          4 (0.9%)           0      
              Missing                     0                0                   0                   0                  0              0      
Total Bilirubin                                                                                                                             
  PL (N=355)                                                                                                                                
              &lt; 3x ULN                    0             6 (1.3%)           32 (3.6%)            6 (0.4%)              0              0      
              &gt;= 3 to &lt; 5x ULN         3 (0.4%)         4 (0.9%)           66 (7.5%)           11 (0.7%)              0              0      
              &gt;= 5 to &lt; 10x ULN        7 (1.0%)        30 (6.7%)          140 (15.9%)          26 (1.7%)              0              0      
              &gt;= 10 to &lt; 20x ULN          0             2 (0.4%)           20 (2.3%)            2 (0.1%)              0              0      
              &gt;= 20x ULN                  0                0                   0                   0                  0              0      
              Missing                     0                0                   0                   0                  0              0      
  T1 (N=318)                                                                                                                                
              &lt; 3x ULN                 1 (0.1%)         5 (1.1%)           30 (3.4%)            4 (0.3%)              0              0      
              &gt;= 3 to &lt; 5x ULN         1 (0.1%)         9 (2.0%)           54 (6.1%)            5 (0.3%)              0              0      
              &gt;= 5 to &lt; 10x ULN        3 (0.4%)        25 (5.6%)          142 (16.1%)          23 (1.5%)              0              0      
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
PL=Placebo, T1=Treatment 1, T2=Treatment 2, ALT=alanine aminotransferase, AST=aspartate aminotransferase, ALP=alkaline phosphatase;
N=number of applicable subjects in treatment arm; n=actual applicable observed number with values.
Table 3
Shifts in Liver Biochemical Tests Based on Thresholds
&lt;Analysis Set&gt;
                                                                             Maximum Post−Baseline Result
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Maximum Baseline Value                 &lt; 3x ULN     &gt;= 3 to &lt; 5x ULN   &gt;= 5 to &lt; 10x ULN   &gt;= 10 to &lt; 20x ULN    &gt;= 20x ULN       Missing   
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Total Bilirubin                                                                                                                             
  T1 (N=318)                                                                                                                                
              &gt;= 10 to &lt; 20x ULN          0             2 (0.4%)           13 (1.5%)            1 (0.1%)              0              0      
              &gt;= 20x ULN                  0                0                   0                   0                  0              0      
              Missing                     0                0                   0                   0                  0              0      
  T2 (N=326)                                                                                                                                
              &lt; 3x ULN                    0             6 (1.3%)           28 (3.2%)            8 (0.5%)              0              0      
              &gt;= 3 to &lt; 5x ULN         2 (0.3%)         5 (1.1%)           64 (7.2%)            8 (0.5%)              0              0      
              &gt;= 5 to &lt; 10x ULN        2 (0.3%)        30 (6.7%)          138 (15.6%)          23 (1.5%)              0              0      
              &gt;= 10 to &lt; 20x ULN          0             3 (0.7%)           8 (0.9%)             1 (0.1%)              0              0      
              &gt;= 20x ULN                  0                0                   0                   0                  0              0      
              Missing                     0                0                   0                   0                  0              0      
ALP                                                                                                                                         
  PL (N=355)                                                                                                                                
              &lt; 3x ULN               187 (26.6%)       99 (22.2%)          2 (0.2%)                0                  0              0      
              &gt;= 3 to &lt; 5x ULN        45 (6.4%)        22 (4.9%)               0                   0                  0              0      
              &gt;= 5 to &lt; 10x ULN           0                0                   0                   0                  0              0      
              &gt;= 10 to &lt; 20x ULN          0                0                   0                   0                  0              0      
              &gt;= 20x ULN                  0                0                   0                   0                  0              0      
              Missing                     0                0                   0                   0                  0              0      
  T1 (N=318)                                                                                                                                
              &lt; 3x ULN               178 (25.3%)       87 (19.6%)              0                   0                  0              0      
              &gt;= 3 to &lt; 5x ULN        33 (4.7%)        19 (4.3%)               0                   0                  0              0      
              &gt;= 5 to &lt; 10x ULN        1 (0.1%)            0                   0                   0                  0              0      
              &gt;= 10 to &lt; 20x ULN          0                0                   0                   0                  0              0      
              &gt;= 20x ULN                  0                0                   0                   0                  0              0      
              Missing                     0                0                   0                   0                  0              0      
  T2 (N=326)                                                                                                                                
              &lt; 3x ULN               193 (27.5%)       71 (16.0%)          1 (0.1%)                0                  0              0      
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
PL=Placebo, T1=Treatment 1, T2=Treatment 2, ALT=alanine aminotransferase, AST=aspartate aminotransferase, ALP=alkaline phosphatase;
N=number of applicable subjects in treatment arm; n=actual applicable observed number with values.
Table 3
Shifts in Liver Biochemical Tests Based on Thresholds
&lt;Analysis Set&gt;
                                                                             Maximum Post−Baseline Result
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
Maximum Baseline Value                 &lt; 3x ULN     &gt;= 3 to &lt; 5x ULN   &gt;= 5 to &lt; 10x ULN   &gt;= 10 to &lt; 20x ULN    &gt;= 20x ULN       Missing   
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
ALP                                                                                                                                         
  T2 (N=326)                                                                                                                                
              &gt;= 3 to &lt; 5x ULN        46 (6.5%)        15 (3.4%)               0                   0                  0              0      
              &gt;= 5 to &lt; 10x ULN           0                0                   0                   0                  0              0      
              &gt;= 10 to &lt; 20x ULN          0                0                   0                   0                  0              0      
              &gt;= 20x ULN                  0                0                   0                   0                  0              0      
              Missing                     0                0                   0                   0                  0              0      
−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−−
PL=Placebo, T1=Treatment 1, T2=Treatment 2, ALT=alanine aminotransferase, AST=aspartate aminotransferase, ALP=alkaline phosphatase;
N=number of applicable subjects in treatment arm; n=actual applicable observed number with values.
</pre>
</body>
</html>